Cell Reports (Oct 2016)
Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host Death
- Frederick J. Kohlhapp,
- Erica J. Huelsmann,
- Andrew T. Lacek,
- Jason M. Schenkel,
- Jevgenijs Lusciks,
- Joseph R. Broucek,
- Josef W. Goldufsky,
- Tasha Hughes,
- Janet P. Zayas,
- Hubert Dolubizno,
- Ryan T. Sowell,
- Regina Kühner,
- Sarah Burd,
- John C. Kubasiak,
- Arman Nabatiyan,
- Sh’Rae Marshall,
- Praveen K. Bommareddy,
- Shengguo Li,
- Jenna H. Newman,
- Claude E. Monken,
- Sasha H. Shafikhani,
- Amanda L. Marzo,
- Jose A. Guevara-Patino,
- Ahmed Lasfar,
- Paul G. Thomas,
- Edmund C. Lattime,
- Howard L. Kaufman,
- Andrew Zloza
Affiliations
- Frederick J. Kohlhapp
- Section of Surgical Oncology, Division of Surgical Oncology Research, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA
- Erica J. Huelsmann
- Department of Immunology/Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
- Andrew T. Lacek
- Department of Immunology/Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
- Jason M. Schenkel
- Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN 55455, USA
- Jevgenijs Lusciks
- Department of Immunology/Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
- Joseph R. Broucek
- Department of General Surgery, Rush University Medical Center, Chicago, IL 60612, USA
- Josef W. Goldufsky
- Department of Immunology/Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
- Tasha Hughes
- Department of General Surgery, Rush University Medical Center, Chicago, IL 60612, USA
- Janet P. Zayas
- Department of Immunology/Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
- Hubert Dolubizno
- Department of Immunology/Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
- Ryan T. Sowell
- Department of Immunology/Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
- Regina Kühner
- Department of Immunology/Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
- Sarah Burd
- University of Oxford, Oxford OX1 2JD, UK
- John C. Kubasiak
- Department of General Surgery, Rush University Medical Center, Chicago, IL 60612, USA
- Arman Nabatiyan
- Department of Immunology/Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
- Sh’Rae Marshall
- Section of Surgical Oncology, Division of Surgical Oncology Research, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA
- Praveen K. Bommareddy
- Section of Surgical Oncology, Division of Surgical Oncology Research, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA
- Shengguo Li
- Section of Surgical Oncology, Division of Surgical Oncology Research, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA
- Jenna H. Newman
- Section of Surgical Oncology, Division of Surgical Oncology Research, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA
- Claude E. Monken
- Section of Surgical Oncology, Division of Surgical Oncology Research, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA
- Sasha H. Shafikhani
- Department of Immunology/Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
- Amanda L. Marzo
- Department of Immunology/Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
- Jose A. Guevara-Patino
- Department of Surgery, Immunology Institute, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL 60153, USA
- Ahmed Lasfar
- Section of Surgical Oncology, Division of Surgical Oncology Research, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA
- Paul G. Thomas
- Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
- Edmund C. Lattime
- Section of Surgical Oncology, Division of Surgical Oncology Research, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA
- Howard L. Kaufman
- Section of Surgical Oncology, Division of Surgical Oncology Research, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA
- Andrew Zloza
- Section of Surgical Oncology, Division of Surgical Oncology Research, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA
- DOI
- https://doi.org/10.1016/j.celrep.2016.09.068
- Journal volume & issue
-
Vol. 17,
no. 4
pp. 957 – 965
Abstract
In light of increased cancer prevalence and cancer-specific deaths in patients with infections, we investigated whether infections alter anti-tumor immune responses. We report that acute influenza infection of the lung promotes distal melanoma growth in the dermis and leads to accelerated cancer-specific host death. Furthermore, we show that during influenza infection, anti-melanoma CD8+ T cells are shunted from the tumor to the infection site, where they express high levels of the inhibitory receptor programmed cell death protein 1 (PD-1). Immunotherapy to block PD-1 reverses this loss of anti-tumor CD8+ T cells from the tumor and decreases infection-induced tumor growth. Our findings show that acute non-oncogenic infection can promote cancer growth, raising concerns regarding acute viral illness sequelae. They also suggest an unexpected role for PD-1 blockade in cancer immunotherapy and provide insight into the immune response when faced with concomitant challenges.
Keywords